CEO and President of Protalix BioTherapeutics Inc (PLX, Financial) David Aviezer sells 244,238 shares of PLX on 10/21/2009 at an average price of $9.43 a share.
ORTHODONTIX INC. is engaged in the provision of practice management services to the Affiliated Practices pursuant to long-term Administrative Services Agreements with separately organized affiliated professional associations. Under the Administrative Services Agreements they have control over all non-orthodontic functions of the PA Contractors including administrative management billing and support functions. Protalix Biotherapeutics Inc has a market cap of $622.6 million; its shares were traded at around $9.13 .
ORTHODONTIX INC. is engaged in the provision of practice management services to the Affiliated Practices pursuant to long-term Administrative Services Agreements with separately organized affiliated professional associations. Under the Administrative Services Agreements they have control over all non-orthodontic functions of the PA Contractors including administrative management billing and support functions. Protalix Biotherapeutics Inc has a market cap of $622.6 million; its shares were traded at around $9.13 .
Insiders' Positions with PLX
- Sell:: President & CEO on 05/12/2009 David Aviezer sold 100,000 shares of PLX stock at the average price of 3.41, the price of the stock has increased by 167.74% since
- Sell:: President & CEO on 05/06/2009 David Aviezer sold 75,000 shares of PLX stock at the average price of 3.03, the price of the stock has increased by 201.32% since
Insiders' Positions with PLX
- Sell:: VP, CFO on 10/16/2009 Yossi Maimon sold 150,000 shares of PLX stock at the average price of 9.46, the price of the stock has decreased by 3.49% since
- Sell:: VP, CFO on 07/07/2009 Yossi Maimon sold 50,000 shares of PLX stock at the average price of 5.11, the price of the stock has increased by 78.67% since
- Sell:: VP, CFO on 05/18/2009 Yossi Maimon sold 30,000 shares of PLX stock at the average price of 4, the price of the stock has increased by 128.25% since
Insiders' Positions with PLX
- Sell:: Executive VP, R&D on 10/19/2009 Yoseph Shaaltiel sold 100,000 shares of PLX stock at the average price of 9.41, the price of the stock has decreased by 2.98% since
- Sell:: VP, Product Development on 10/19/2009 Einat Brill Almon sold 90,000 shares of PLX stock at the average price of 9.41, the price of the stock has decreased by 2.98% since
- Sell:: 10% Owner on 09/10/2009 Phillip Md Et Al Frost sold 178,074 shares of PLX stock at the average price of 7.47, the price of the stock has increased by 22.22% since
- Sell:: 10% Owner on 09/03/2009 Phillip Md Et Al Frost sold 75,000 shares of PLX stock at the average price of 6.89, the price of the stock has increased by 32.51% since
- Sell:: 10% Owner on 08/28/2009 Phillip Md Et Al Frost sold 67,307 shares of PLX stock at the average price of 6.01, the price of the stock has increased by 51.91% since
